Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More

Global IP professionals gather to share knowledge and experiences and discuss the future of IP

BOSTON, May 30, 2024 (GLOBE NEWSWIRE) — Anaqua, the leading provider of innovation and intellectual property (IP) management technology, today announces a lineup of top-tier IP speakers and panelists for its 15th annual Anaqua Experience Conference (AEC). The event, taking place in Boston, MA, from June 24-27, 2024, will bring together IP and business leaders from across the globe to share knowledge and experiences, and to discuss the future of IP – with a particular focus on the impact of AI in the industry.

Attendees will hear from industry experts, engage in networking events, and participate in Anaqua-led training sessions, learning new features in AQX® 11 – Anaqua’s most significant IP management platform release in 20 years – to help further optimize their IP management processes.

“This is an exciting time for the IP industry as we embrace new technologies, including AI, which could have far-reaching effects on how the industry operates,” said Bob Romeo, CEO of Anaqua. “We are proud to bring together the most innovative companies and law firms across the globe at our client conference. By connecting the entire IP community, we can move forward together to address our industry’s new issues and developments.”

Kicking off the conference is a keynote presentation from former Under Secretary of Commerce and USPTO Director David Kappos, Co-Chair of Cravath’s Intellectual Property Practice, on the macro-level trends shaping the future of IP. Other conference keynotes will delve into the specific effects of AI for IP, and will include:

  • Olga V. Mack – Renowned general counsel, IP attorney, digital transformation executive, author, and Above the Law + ACC Docket Legal Tech & Future of Law columnist, discussing the increasing value of human time in the age of advanced AI.
  • Stephen R. Perry – Creative Director at Bailey Brand Consulting, examining the impact of AI on the creative process and brand development.
  • Panel Discussion – Exploring the balance of risks, value, and efficacy when deploying AI in IP practice, featuring Raghu Chinagudabha of Microsoft; Sunjay Mohan of SAP; and Matthew Sked of the USPTO.

“What’s always so rewarding about The Anaqua Experience Conference is watching this global community of industry professionals, who are passionate about the advancement of IP, share their thoughts, insights, and experiences in a truly collaborative and interactive environment,” said Aileen Buchanan, Vice President, Client Success of Anaqua.

The conference will also host several sessions by many IP industry leaders, including:

  • Thomas H. Walls – Bausch Health Companies
  • Beth McGraw – Eli Lilly and Company
  • Gitte Berthelsen Lerche and Ana-Maria Macovetchi – Novo Nordisk
  • Tomoe Itoh – Otsuka Pharmaceutical Co., Ltd.
  • Will Federspiel – Reebok
  • Elizabeth Swift – RTX Corporation
  • Camylle Wnek – Techtronic Industries (TTI)

The 2024 AEC will be held at the Renaissance Boston Waterfront Hotel, starting with a welcome reception on the evening of June 24, a full day of training sessions on June 25, followed by a series of presentations and panel discussions through to June 27. Registration remains open until June 25.

To register for the event, visit https://cvent.me/RY7ZLg.

About Anaqua
Anaqua, Inc. is a premier provider of integrated intellectual property (IP) management technology solutions and services for corporations and law firms. Its IP management software solutions, AQX® and PATTSY WAVE®, both offer best practice workflows with big data analytics and tech-enabled services to create an intelligent environment designed to inform IP strategy, enable IP decision-making, and streamline IP operations, tailored to each segment’s need. Today, nearly half of the top 100 U.S. patent filers and global brands, as well as a growing number of law firms worldwide use Anaqua’s solutions. Over one million IP executives, attorneys, paralegals, administrators, and innovators use the platform for their IP management needs. The company’s global operations are headquartered in Boston, with offices across the U.S., Europe, Asia, and Australia. For additional information, please visit anaqua.com, or on Anaqua’s LinkedIn.

Company Contact:
Amanda Glagolev
Director, Communications
Anaqua
617-375-5808
[email protected]

GlobeNewswire Distribution ID 9145896

Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research

Leverages real-world data, patient insights and a systematic process to design, operationalize and measure the effectiveness of diversity action plans in clinical trials

DURHAM, N.C., May 30, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced its comprehensive and integrated solution to improve the diversity and inclusion (D&I) of participants in clinical trials. Fortrea’s D&I solution is designed to expand patient access to participate in clinical trials and address the U.S. Food and Drug Administration (FDA) requirements, under The Food and Drug Omnibus Reform Act, to increase enrollment of underrepresented populations in clinical trials.

Fortrea’s comprehensive process integrates five components of diversity action planning and execution:

  • Real-world evidence advisors research relevant real-world data sets to inform diversity planning.
  • Regulatory, development and clinical operational experts design the Diversity Action Plan, validate with patient groups and negotiate with regulators.
  • Operational teams access multiple data platforms, Fortrea’s Site Advisory Board and technology-enabled solutions to implement the Diversity Action Plan as an integral part of Fortrea’s clinical trial execution.
  • Monitoring and reporting are enabled by Fortrea’s exclusive Diversity and Inclusion Study Insights Dashboard, providing actionable data and visualizations for ongoing study management.
  • Experienced report technical writers compile data and prepare reports for regulatory submission, with ongoing regulatory support provided as part of the D&I solution.

“Clinical research that reflects a representative population provides better insight into how a potential treatment will work in a real-world setting,” said John Doyle, DrPH, president Fortrea Consulting. “Recent regulatory requirements codify progress over the last few years in biopharma’s approach to improving the inclusion of diverse populations in their development programs. Fortrea’s solution brings deep, real-world data expertise to design D&I plans that are effective and realistic, along with more than 30 years of experience across more than 20 therapeutic areas in trial execution. We also bring a steadfast commitment to D&I, not just in clinical trials but across our entire company as we pursue our purpose of bringing life-changing treatments to patients faster.”

Fortrea’s D&I solution incorporates a series of proprietary tools, including epidemiological and feasibility assessments that leverage an exclusive combination of large data sets. The solution also integrates inputs from patient groups to create insights into protocol tolerance and study conduct support requirements in different patient populations across multiple therapy areas and geographies. These insights inform global and local patient recruitment and retention plans to reach under-represented patient populations and address barriers to participation in clinical trials.

“Ensuring the inclusion of diverse patient populations in clinical trials must go beyond a plan, it takes insight and action,” said Mark Morais, chief operating officer, Fortrea. “Because of our comprehensive Voice of Patient program and our collaboration with diverse investigator sites and site networks, we have a deep understanding of what it takes to be successful in reaching populations that have traditionally been under-represented in clinical trials. At Fortrea, we are informed by real-world data, enabled by innovative technologies, and driven by our passion to deliver new therapies for all patients.”

Please visit Diversity and Inclusion in Clinical Trials on Fortrea.com for more information.

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life-changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, consulting services, differentiated technology enabled trial solutions and post-approval services.

Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally.

Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter) @Fortrea.

Fortrea Contacts:
Fortrea Media: Galen Wilson – 703-298-0802, [email protected]
Fortrea Media: Kate Dillon – 646-818-9115, [email protected]

GlobeNewswire Distribution ID 9146130

Axi launches their biggest global trading competition ever, with $250,000 USD up for grabs

The trading competition is to have 49 winners including a grand prize of $100,000 USD

SYDNEY, Australia, May 30, 2024 (GLOBE NEWSWIRE) — Leading online FX and CFD broker Axi has launched 2024’s biggest global trading competition, with a total prize pool of $250,000 USD.

Axi is shaking the waves, inviting traders of all sizes to trade their edge and win mega prizes, including the grand prize of $100,000 USD. Over 45 prizes will be given for ROI, top trading volume, best ROI each week, as well as five random prizes of $500 USD per week.

Registration for the competition has commenced, and the four-week contest is set to run from June 3 to June 30. Per the broker, the competition is open both for new or existing clients, and ambitious traders who are interested in participating should open or already have a live trading account with Axi, deposit a minimum of $200, and trade at least 1 lot.

Louis Cooper, Chief Commercial Officer at Axi, shares his excitement for the upcoming competition: “‘Trade Your Edge’ is our strapline, and in June we invite our traders to do just that – trade their edge on their favourite markets like Forex, Gold, Crypto, for a chance to win amazing cash prizes, including the top prize of $100,000 USD.

This has been a very successful financial year for the broker; they’ve recently introduced cutting-edge new programmes and have also expanded their partnership portfolio to include Man City Women, LaLiga club Girona FC, and England international and six-time Premier League winner John Stones as the company’s Brand Ambassador.

To learn more about the competition and register, visit:

https://www.axi.com/int/promotions/global-trading-competition

About Axi

Axi is a global online FX and CFDs trading broker. As the preferred broker for thousands of ambitious customers in over 100 countries worldwide, we help all types of traders, trading businesses, banks and financial organizations find the edge they need to achieve their financial goals through informed transactions made on the world’s financial markets. Axi offers a comprehensive range of assets including CFDs for several asset classes such as Forex, Shares, Oil, Precious Metals, Coffee, Indices, and other commodities.

At Axi, we take pride in our reputation as an honest, fair, and responsible broker. Our numerous global awards and reviews attest to the confidence and trust we have earned from our customers who value our exceptional service, fast execution, secure payments, and easy withdrawals. Similarly, we also work pro-actively with leading regulatory governing authorities around the world to ensure that we surpass the highest industry standards.

The trading competition is only available to clients of AxiTrader Limited. CFDs carry a high risk of investment loss. Not available to AU, NZ, EU & UK residents. T&Cs apply.

For more information or additional comments from Axi, please contact: Media.Enquiries@axi.com

GlobeNewswire Distribution ID 1000963491

‫فين فاست توقع اتفاقية بيع حصرية في الإمارات العربية المتحدة مع الطاير للسيارات

هانوي، فيتنام – 30 مايو 2024 – وقعت شركة فين فاست للسيارات رسميًا اتفاقية بيع حصرية مع أحد وكلاء السيارات الأوائل في الإمارات العربية المتحدة، شركة الطاير للسيارات، لتوزيع سيارات فين فاست الكهربائية (EV) في البلاد. ومن المقرر افتتاح المنشأة الافتتاحية في عام 2024، وسيُباع أربعة موديلات من سيارات فين فاست الكهربائية الرياضية، وهي VF 6 وVF 7 وVF 8 وVF 9.

السيد تا شوان هين، الرئيس التنفيذي لشركة فين فاست الشرق الأوسط (الرابع من اليسار)، والسيد سعيد الطاير، المدير العام لشركة الطاير للسيارات (الرابع من اليمين)، إلى جانب كبار الممثلين من الجانبين في حفل التوقيع.

وستكون شركة الطاير للسيارات الشريك الحصري لشركة فين فاست في دولة الإمارات العربية المتحدة وتخطط لإنشاء شبكة من منشآت فين فاست في جميع أنحاء البلاد. تعد شركة الطاير للسيارات، الحائزة على العديد من الجوائز، والتي تأسست عام 1982، واحدة من الشركات الرائدة في مجال السيارات في دولة الإمارات العربية المتحدة وتمثل كبرى شركات تصنيع السيارات الأوروبية والأمريكية.

ومن خلال شبكة تتوسع باستمرار من مراكز المبيعات والخدمة وقطع الغيار، إلى جانب فريق مكون من 2700 موظف، تلتزم شركة الطاير للسيارات بتوفير تجارب استثنائية للعملاء من خلال بنيتها التحتية المادية الرائعة ومنصاتها الرقمية المتطورة، بما في ذلك التجارة الإلكترونية وتطبيقها المخصص.

وبتعزيز التعاون مع الشركاء الرائدين في دولة الإمارات العربية المتحدة والشرق الأوسط، تساهم فين فاست بنشاط في تحقيق حلول التنقل الأخضر داخل المنطقة، مع التأكيد على التزام الشركة المصنعة للمركبات الكهربائية الفيتنامية بجعلها في متناول الجميع.

قال السيد تا شوان هين، الرئيس التنفيذي لشركة فين فاست الشرق الأوسط: “تعد الاتفاقية مع شركة الطاير للسيارات إنجازًا مهمًا في استراتيجية التوسع في السوق العالمية لشركة فين فاست. نحن نؤمن بأن هذا الشريك ذو السمعة الطيبة وذو الخبرة سيساعد فين فاست على تقديم منتجات وخدمات عالية الجودة للعملاء في دولة الإمارات العربية المتحدة. وتلتزم فين فاست بتزويد العملاء بخيارات التنقل بالسيارات الكهربائية الذكية والصديقة للبيئة، مع المساهمة في تحقيق أهداف التنمية المستدامة لدولة الإمارات العربية المتحدة.

 وقال السيد أشوك خانا، الرئيس التنفيذي لشركة الطاير للسيارات: “نحن متحمسون لإطلاق فين فاست في دولة الإمارات العربية المتحدة – مركز دولي نابض بالحياة للغاية. نحن نؤمن بأن هذه الشراكة بين الطاير للسيارات وفين فاست ستوفر تجربة السيارات الكهربائية المثالية لعملاء الإمارات العربية المتحدة مع تضخيم العلامة التجارية عالميًا. وبفضل خبرتنا الواسعة وفرقنا المتفانية ونهجنا الذي يركز على العملاء، فإننا نجعل ملكية السيارة أسهل من أي وقت مضى ونضع أفضل الممارسات على المستوى المحلي والعالمي.

منذ الربع الرابع من عام 2023، غيرت فين فاست استراتيجيتها من نموذج المبيعات المباشرة للمستهلكين إلى نموذج هجين من خلال الاستفادة من البنية التحتية للتوزيع الحالية من خلال إنشاء شبكة وكلاء عالمية. ومن المتوقع أن تساهم المبيعات من خلال التجار بشكل كبير في مبيعات فين فاست في النصف الثاني من عام 2024.

بالإضافة إلى الأسواق الرئيسية مثل الولايات المتحدة وكندا وأوروبا، تتوسع فين فاست بسرعة في البلدان المجاورة في آسيا مثل الهند وإندونيسيا وتايلاند والفلبين، وكذلك الشرق الأوسط وأفريقيا.

  حول فين فاست

تسعى فين فاست – عضو فين جروب – إلى قيادة التقدم في ثورة السيارات الكهربائية الذكية العالمية. تأسست فين فاست في عام 2017، وتمتلك مجمعًا متطورًا لتصنيع السيارات يتمتع بقابلية تطوير رائدة عالميًا ويتميز بأتمتة تصل إلى 90 بالمائة في هاي فونج، فيتنام.

تلتزم فين فاست بشدة بمهمة المستقبل المستدام للجميع، وتبتكر باستمرار لتقديم منتجات عالية الجودة وخدمات ذكية متقدمة وتجارب عملاء سلسة واستراتيجية تسعير للجميع لإلهام العملاء العالميين لخلق مستقبل من التنقل الذكي والمستدام. تعرف على المزيد على: https://vinfastauto.com/vn_en

World No Tobacco Day: Addressing the “Misperception Epidemic”

World Vapers’ Alliance in Geneva

World Vapers’ Alliance in Geneva

GENEVA, May 30, 2024 (GLOBE NEWSWIRE) — On this World No Tobacco Day, the World Vapers Alliance (WVA) is shedding light on the rampant misperception epidemic around tobacco harm reduction. As revealed by Ipsos research for the think tank, We are Innovation, a staggering 74% of smokers worldwide mistakenly believe that vaping is as harmful or more harmful than smoking. This widespread misunderstanding is the result of misinformation and costs lives, as millions of smokers waver on making the switch to a scientifically proven, 95% less harmful alternative product.

“World No Tobacco Day is a crucial opportunity to combat misinformation and promote effective harm reduction strategies,” said Michael Landl, Director of the World Vapers Alliance. “Instead of blindly fighting against safer nicotine alternatives, the WHO should be championing them as the key to a smoke-free future.”

Sweden has set a remarkable precedent by embracing harm reduction. The country is on the verge of becoming smoke-free, not by banning safer nicotine products but by endorsing them. Sweden’s success should serve as a model for global tobacco harm reduction strategies. The World Health Organization (WHO) should take note and adapt its current approach, which is failing.

Landl added, The WHO is missing the mark by targeting vaping and other safer nicotine products instead of focusing on the real threat – smoking. By fighting those products, they are keeping smokers from making the switch. This is not just misguided, it’s dangerous.”

The misperception that vaping is equally harmful as smoking is a public health crisis in itself. Evidence from numerous studies, including comprehensive reviews by Public Health England, confirms that vaping is significantly less harmful than smoking.

“We are facing a misperception epidemic and the WHO is part of the problem by spreading further misconceptions,” Landl stated. Accurate information is the cornerstone of effective public health policy. We must ensure that smokers have access to the truth about safer alternatives. Facts over lies!”

The World Vapers Alliance is calling on health authorities and the WHO to reevaluate their stance on harm reduction and to prioritize facts over fear. It is essential to support policies that promote safer alternatives to smoking rather than vilifying them.

In conjunction with these efforts, the WVA organized a protest in front of the WHO headquarters on World Vape Day, May 30th.

World Vapers' Alliance in Geneva

This demonstration aimed to compel the WHO to finally listen to consumers and acknowledge the scientific evidence in support of vaping, nicotine pouches and similar products as valid harm-reduction tools. It is high time the World Health Organization acknowledge reality, embrace science and help move the world toward a healthier future. Turns out, it’s as easy as giving people more choices, not less.

For media enquiries, please contact:

Michael Landl
Director of the World Vapers’ Alliance
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0037ce8c-ca1f-48da-b4d3-384f0718d4a9

GlobeNewswire Distribution ID 9145908

WHO Misinformation ‘Harming Public Health and Turning African Smokers Away From Lifesaving Vapes’ – New Poll

World Vapers’ Alliance in Geneva

World Vapers’ Alliance in Geneva

ABUJA, Nigeria, May 30, 2024 (GLOBE NEWSWIRE) — The World Vapers’ Alliance, Campaign For Safer Alternatives (CASA), Foundation for Consumer Freedom Advancement and THR Nigeria have condemned the results of a new poll showing 70% of smokers in Nigeria and 69% in Kenya (74% worldwide) incorrectly believe vaping is equally as harmful as smoking.

This Misinformation Epidemic, revealed in research by Ipsos for the think tank network We Are Innovation, has been blamed on repeated statements from key institutions such as the World Health Organization (WHO).

In the last six months alone, the WHO has published vaping and nicotine misinformation on more than ten occasions, including statements suggesting that vaping causes cancer and asserting that vapes often contain more toxicants than cigarettes.

This goes against most recent research and statements from public health authorities such as the UK’s National Health Service. The latter has published a guide to “Vaping Myths and Facts”, debunking some of the most significant misconceptions about vaping to help smokers access high-quality information.

Indeed, the countries that have been most successful in reducing smoking rates, such as Sweden and New Zealand, have embraced smoke-free nicotine alternatives in recent years, thereby significantly reducing smoking prevalence.

Sweden, which initiated the process much earlier, has already seen significant progress in public health outcomes, including an incidence of lung cancer death 41% lower than the EU average.

Commenting on the misinformation epidemic on World Vape Day, World Vapers’ Alliance director Michael Landl said: “The WHO is neglecting its responsibility to the world’s 1.1 billion smokers and is actively providing fearmongering, false information, depriving them of what has been proven to be the most successful tool we have in the fight against smoking.”

“Vaping is 95% less harmful than smoking. Public health officials have a responsibility to tell smokers this and save millions of lives in the process,” added Joseph Magero, Chairman at CASA.

“We have a unique opportunity to lead by example and prioritize harm reduction. By embracing safer nicotine alternatives, we can significantly reduce smoking rates and improve public health,” stated Uche Olatunji, Project Manager at THR Nigeria.

For media enquiries, please contact:

Michael Landl
Director of the World Vapers’ Alliance
[email protected]

About World Vapers Alliance:

The World Vapers’ Alliance (WVA) amplifies the voices of vapers worldwide and empowers them to make a difference in their communities. Our members are vapers associations as well as individual vapers from all over the world.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3c8017ea-1b7a-42f3-b258-574bdff12ffe

GlobeNewswire Distribution ID 9145701